Macrogenics Inc

Ownership Transactions Reported by 20 Insiders

Symbol
MGNX on Nasdaq
Industry
Pharmaceutical Preparations
Location
9704 Medical Center Drive, Rockville, MD

Insiders trading volume in the past year

Macrogenics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Biotech Target N V 10%+ Owner $119M Oct 2, 2023
Scott Koenig President and CEO, Director $20.6M Oct 7, 2024
Eric Blasius Risser Chief Operating Officer $4.18M -$814K -16.3% Mar 4, 2024
James Karrels SVP, CFO and Secretary $4.16M -$615K -12.9% Mar 4, 2024
Thomas Spitznagel Sr VP, Technical Ops $2.04M -$200K -8.93% Mar 4, 2024
Ezio Bonvini Sr VP, Research & CSO $1.86M -$610K -24.7% Feb 22, 2024
Jeffrey Stuart Peters Senior VP and General Counsel $1.29M -$2.76M -68.1% Apr 4, 2024
Lynn Cilinski VP, Controller and Treasurer $1.16M Feb 15, 2024
Edward Hurwitz Director $971K May 21, 2024
Stephen L. Eck Chief Medical Officer $886K Feb 15, 2024
William K. Heiden Director $368K May 21, 2024
David C. Stump Director $368K May 21, 2024
Karen Jean Ferrante Director $368K May 21, 2024
Scott Thomas Jackson Director $368K May 21, 2024
Federica F. O'Brien Director $368K May 21, 2024
Meenu Chhabra Director $323K May 21, 2024
Margaret Liu Director $261K May 21, 2024
Jay Philip Siegel Director $261K May 21, 2024
Paulo F. Costa Director $22.7K May 13, 2021
Kenneth Galbraith Director $22.7K May 13, 2021

Recent Insider Transactions by Companies or Individuals for Macrogenics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.